Pathstone Family Office’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $4.68M | Buy |
|
|||||
|
2023
Q2 | $2.32M | Buy |
|
|||||
|
2023
Q1 | $2.64M | Sell |
|
|||||
|
2022
Q4 | $5.84M | Buy |
|
|||||
|
2022
Q3 | $5.15M | Buy |
|
|||||
|
2022
Q2 | $681K | Buy |
|
|||||
|
2022
Q1 | $802K | Buy |
|
|||||
|
2021
Q4 | $649K | Buy |
|
|||||
|
2021
Q3 | $288K | Sell |
|
|||||
|
2021
Q2 | $285K | Buy |
|
|||||
|
2021
Q1 | $239K | Buy |
|
|||||
|
2020
Q4 | $166K | Buy |
|
|||||
|
2020
Q3 | $57K | Hold |
|
|||||
|
2020
Q2 | $63K | Sell |
|
|||||
|
2020
Q1 | $60K | Sell |
|
|||||
|
2019
Q4 | $518K | Buy |
|
|||||
|
2019
Q3 | $28K | Hold |
|
|||||
|
2019
Q2 | $31K | Sell |
|
|||||
|
2019
Q1 | $50K | Buy |
|
|||||
|
2018
Q4 | $8K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $11K | Buy |
|